EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Targeting colorectal cancer and T‑cell metabolism for the treatment of colorectal cancer (Review)

Qiangzong Yu, Pengbo Luan, Jingru Liang, Lixin Wang

Oncology Reports · 02.06.2026 · 56 (2) · 1-12

DOI: 10.3892/or.2026.9147 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Oncology Reports, online erschienen am 02.06.2026. Verfasst von Qiangzong Yu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Yantaishan Hospital, Yantai, Shandong 264003, P.R. China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, T-Lymphocytes. Die Arbeit nennt 137 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is a malignant tumor of the digestive tract that is highly prevalent worldwide, which is associated with a poor prognosis in advanced stages and for which current treatment plans have limited efficacy.T cells serve a crucial role in immune clearance and immune evasion within the tumor microenvironment.However, tumor cells directly impair the function of T cells through nutrient competition and the release of inhibitory metabolites.Notably, targeting 'metabolic checkpoints' has emerged as a crucial strategy to enhance T-cell efficacy.The present literature review summarizes the role of reprogramming glycolysis, glutaminolysis and lipid metabolism in driving immune evasion in CRC, and discusses potential intervention strategies from two perspectives: Modulating tumor metabolism and optimizing the intrinsic metabolic functions of T cells.Finally, it is proposed that stratified precision therapy based on individual metabolic profiles represents a future direction for overcoming immune heterogeneity and drug resistance in CRC.Contents 1.

Introduction

2. Metabolic characteristics and immunosuppressive environment of CRC 3. Modulation of tumor metabolism 4. T-cell metabolism 5. Targeting T-cell metabolism 6.

Discussion

7. Conclusion and prospects

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsT-LymphocytesHumansTumor MicroenvironmentMetabolic ReprogrammingTumor EscapeLipid MetabolismGlycolysisAnimalsMolecular Targeted TherapyDrug Resistance, Neoplasm

Stichwörter der Autor:innen

T cellcolorectal cancermetabolic checkpointsmetabolic reprogrammingtumor microenvironment

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, Yantaishan Hospital, Yantai, Shandong 264003, P.R. China.

Zitieren

APA

Yu, Q., Luan, P., Liang, J., & Wang, L. (2026). Targeting colorectal cancer and T‑cell metabolism for the treatment of colorectal cancer (Review). Oncology Reports, 56(2), 1-12. https://doi.org/10.3892/or.2026.9147

Vancouver

Yu Q, Luan P, Liang J, Wang L. Targeting colorectal cancer and T‑cell metabolism for the treatment of colorectal cancer (Review). Oncology Reports. 2026;56(2):1-12. doi:10.3892/or.2026.9147

BibTeX
@article{Yu2026,
  author = {Yu, Qiangzong and Luan, Pengbo and Liang, Jingru and Wang, Lixin},
  title = {Targeting colorectal cancer and T‑cell metabolism for the treatment of colorectal cancer (Review)},
  journal = {Oncology Reports},
  year = {2026},
  volume = {56},
  number = {2},
  pages = {1--12},
  doi = {10.3892/or.2026.9147}
}
Kostenlos starten →